For nearly four decades, a single sentence buried in the tax code did something almost no other provision does: it told a legal, state-licensed business that it could not deduct rent, payroll, or marketing from its taxable income. That sentence is Section 280E, and on April 22, 2026, it stopped applying to a meaningful slice of the cannabis industry for the first time since it was written.
If you run — or advise — a state-licensed medical cannabis business, this is not a minor regulatory footnote. It is potentially the largest single change to your effective tax rate you will ever see. If you run a recreational-only dispensary or grow, the news is almost the opposite: nothing changed for you at all, and understanding exactly where the line falls now matters more than ever.
What Section 280E Actually Did
Section 280E of the Internal Revenue Code denies all business expense deductions — the ordinary things every other business writes off under IRC §162(a), like rent, salaries, utilities, marketing, and insurance — to any business "trafficking" in a Schedule I or Schedule II controlled substance. Marijuana has sat on Schedule I, the same tier as heroin, since the Controlled Substances Act was passed in 1970.
The practical effect was brutal. A cannabis retailer could still subtract its cost of goods sold (COGS) from revenue, because COGS isn't a "deduction" in the 280E sense — it's baked into gross income calculation. But everything else was fair game for the IRS to disallow. Dispensaries routinely reported effective federal tax rates of 60–75%+, even in years they were barely profitable on a cash basis, because state licensing fees, security systems, and employee wages simply couldn't offset revenue for federal tax purposes.
This is why cannabis accounting became its own specialized niche: operators fought hard over inventory costing methods under IRC §471 and §471-11, trying to legitimately shift as many indirect costs as possible into COGS, because COGS was the only lever 280E left untouched.
The April 2026 Order: What Changed and Why
On April 22, 2026, the Acting Attorney General signed an order moving certain marijuana products from Schedule I to Schedule III of the Controlled Substances Act, with the DOJ formally announcing it the following day. The rescheduling is narrower than the "full legalization" headlines might suggest — it applies specifically to:
- FDA-approved marijuana products
- Marijuana dispensed under a state medical marijuana license
- Certain marijuana extracts and naturally derived delta-9 THC products falling within those categories
Because Section 280E only applies to Schedule I and Schedule II substances, moving eligible cannabis to Schedule III means 280E no longer applies to those businesses at all. Treasury has indicated that, for most operators, this relief runs for "the first full taxable year that includes the effective date" — meaning many state-licensed medical operators can treat all of 2026 as a 280E-free year, with retrospective relief for the affected period still being clarified through IRS guidance.
The DOJ simultaneously kicked off a new expedited administrative hearing beginning June 29, 2026, to evaluate broader rescheduling — the process that could eventually extend Schedule III treatment (and 280E relief) to the adult-use market too. Until that hearing concludes, though, the line drawn in April holds.
Who Actually Benefits — and Who Doesn't
This is the part worth reading twice, because "cannabis is off Schedule I" is not the same as "my dispensary is off Schedule I."
Relief applies to:
- Businesses holding a state medical marijuana license, selling products that qualify under the order
- FDA-approved cannabis-derived products
- Certain qualifying extracts and naturally derived delta-9 THC formulations
Nothing changed for:
- Adult-use / recreational-only operators. Unlicensed marijuana crops, bulk flower sold into the recreational market, and non-FDA-approved products outside the medical licensing structure remain Schedule I. Section 280E still applies to every dollar of deductible expense for a purely recreational business.
- Any cannabis activity outside the specific medical-license and FDA-approved categories the order names.
The hard case: mixed operators. Many license holders sell into both medical and adult-use channels — think a dispensary with both a medical and recreational storefront, or a cultivator supplying both markets. These businesses now face a genuinely difficult expense-allocation problem: costs tied to the medical, Schedule III side are deductible; costs tied to the recreational, Schedule I side are still subject to 280E. Treasury and the IRS are expected to issue guidance on apportionment methodology, but until that lands, mixed operators are in a documentation-heavy gray zone — and this is exactly the kind of situation where sloppy records turn into an expensive audit.
Putting a Number on It
Abstract percentages don't land the way a real example does, so here's a simplified illustration of what this change can mean for a qualifying medical operator.
Imagine a state-licensed medical dispensary with $2,000,000 in annual revenue, $1,100,000 in cost of goods sold, and $600,000 in other operating expenses (rent, payroll, marketing, insurance, admin).
- Under 280E (pre-rescheduling): Taxable income = Revenue − COGS = $900,000. The $600,000 in operating expenses is entirely non-deductible. At a combined effective federal/state rate in the 35–45% range applied to that inflated taxable base, the business could easily owe more in tax than it actually cleared in cash profit ($2,000,000 − $1,100,000 − $600,000 = $300,000 true pre-tax profit, against a tax bill calculated on $900,000).
- Outside 280E (post-rescheduling, for qualifying medical revenue): Taxable income = Revenue − COGS − Operating expenses = $300,000, the actual economic profit. Tax is calculated on the real number, not a number inflated by disallowed deductions.
That gap — tax on $900,000 versus tax on $300,000 — is the entire story of why 280E relief is such a big deal, and why documenting exactly which revenue and expenses qualify matters so much. A business that can't prove which dollars came from Schedule III–eligible medical sales risks the IRS defaulting to the old, harsher treatment on audit.
What to Do About It Right Now
-
Confirm your license status and product mix, in writing. If any portion of your revenue comes from state-medical-licensed sales of qualifying products, document that split clearly and immediately — by SKU, by register category, by license number if your state issues separate ones. This is the foundation every deduction claim will rest on.
-
Don't assume retroactive relief without guidance. Treasury has signaled openness to "retrospective relief," but the mechanics aren't finalized. Talk to a cannabis-specialized CPA before amending prior-year returns or recognizing deductions you haven't confirmed apply to your specific license and product category.
-
Re-examine your chart of accounts now, not at year-end. If you built your books around the 280E-era discipline of maximizing COGS allocation (because that was the only deductible bucket), you now need parallel tracking: which expenses are Schedule III–eligible deductions versus which remain non-deductible Schedule I costs. Trying to reconstruct that split from a commingled general ledger in April 2027 will be painful and expensive.
-
Watch the June 29, 2026 hearing. If broader rescheduling extends Schedule III status to adult-use cannabis, the calculus changes again for recreational operators — but until a final rule lands, plan around today's rules, not tomorrow's possibility.
-
Get ahead of the mixed-operator allocation problem. If you sell into both medical and recreational channels, start tagging transactions by channel today. Whatever apportionment method the IRS eventually blesses, you'll need granular, timestamped records to apply it — and "we'll figure out the split later" is not a defensible audit position.
Why This Is a Bookkeeping Problem First
Every cannabis operator I've talked to over the past several years has said some version of the same thing: their tax bill wasn't really a tax problem, it was a records problem. The businesses that survived 280E's harshest years weren't necessarily the most profitable ones — they were the ones with clean, defensible, well-documented cost allocation, because that's what let them maximize the one deduction category (COGS) that 280E couldn't touch.
That discipline doesn't disappear now that some of you have deductions back. If anything, it gets more complicated: you need clean channel-level tracking (medical vs. recreational), clean expense categorization (which costs attach to which license), and an audit trail that can survive IRS scrutiny of a genuinely novel tax position. A cannabis business that can't produce a clear, auditable answer to "how much of this expense is attributable to your Schedule III activity" is going to have a rough time claiming the deduction at all.
This is exactly the kind of situation where plain-text, version-controlled bookkeeping earns its keep. When every transaction is a line in a file rather than a locked cell in someone else's proprietary format, tagging by license, by channel, or by product category is a matter of adding a metadata field — and every change to how you categorize things is visible in your history, which matters enormously if the IRS ever asks you to explain your allocation method. Beancount.io gives cannabis operators and their accountants exactly that: transparent, auditable, plain-text accounting with no black-box categorization and no vendor lock-in. Get started for free and build the kind of clean, defensible records that a novel tax position like this one actually requires.